NASDAQ: WOKWork Medical Technology Group Ltd Stock
$3.59-0.17 (-4.52%)
Updated Oct 31, 2025
WOK Price
$3.59
Fair Value Price
-$0.90
Market Cap
$523.85k
52 Week Low
$2.79
52 Week High
$844.63
P/E
-0.13x
P/B
0.04x
P/S
0.77x
PEG
N/A
Dividend Yield
N/A
Revenue
$10.74M
Earnings
-$3.71M
Gross Margin
26.9%
Operating Margin
-31.2%
Profit Margin
-34.5%
Debt to Equity
1.47
Operating Cash Flow
-$4M
Beta
0.79
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
WOK Overview
WORK Medical Technology Group LTD, together with its subsidiaries, manufactures and sells medical consumables in the People's Republic of China and internationally. The company offers disposable medical devices, such as medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half mask; and visualized prostatic dilatation catheters. It also exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine WOK's potential to beat the market
- WOK doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important WOK news, forecast changes, insider trades & much more!
WOK News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how WOK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
WOK ($3.59) is overvalued by 498.68% relative to our estimate of its Fair Value price of -$0.90 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
WOK ($3.59) is not significantly undervalued (498.68%) relative to our estimate of its Fair Value price of -$0.90 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
WOK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more WOK due diligence checks available for Premium users.
Valuation
WOK fair value
Fair Value of WOK stock based on Discounted Cash Flow (DCF)
Price
$3.59
Fair Value
-$0.90
Undervalued by
498.68%
WOK ($3.59) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
WOK ($3.59) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
WOK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
WOK price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.13x
Industry
27.18x
Market
41.55x
WOK price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.04x
Industry
3.86x
WOK is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
WOK's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
WOK's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
WOK's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$34.7M
Liabilities
$19.0M
Debt to equity
1.47
WOK's short-term assets ($21.58M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
WOK's short-term assets ($21.58M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
WOK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
WOK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
WOK vs Medical Device Stocks
Work Medical Technology Group Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.